Oxford, one of the most established universities in the world, continues its studies for the COVID-19 vaccine. Oxford scientists who started the first human tests said they were 80 percent hopeful with the vaccine. Stating that the vaccine may be ready until September, Oxford University stated that they are sure that the developed vaccine will work against coronavirus, according to the news in Sky News. Scientists working at the Jenner Institute, affiliated with Oxford University, have stated that the vaccine will continue its tests until September and will be released when it is proven safe and effective. Specialists, who noted that the vaccine will produce 1 million doses of vaccine for human testing, also explained the reason for the trust in the vaccine. Reporting that the same vaccine technology is used in coronavirus-related diseases such as MERS and Ebola, experts estimate that the vaccine to be produced will therefore be released sooner than expected. Human tests of the vaccine started England, one of the countries most affected by COVID-19, started the first human tests of the vaccine study produced in cooperation with Oxford University and Imperial College. The “ChAdOx1 nCoV-19” vaccine, which was tested on two volunteers, was developed by playing with the genetic “adenovirus” that causes flu in chimpanzees. How does the vaccine work? The COVID-19 virus enters the human body using spike proteins. The ChAdOx1 nCoV-19 vaccine developed by Oxford University allows the body to recognize the spike protein and prevent the virus from entering the body by giving an immune response. Healthy people take the vaccine test Healthy people who volunteer during the testing process of the coronavirus vaccine are selected. The vaccine, which will be administered to 1102 volunteers between the ages of 18 and 55 in the first place, will be administered to at least 5000 people in further comprehensive tests. Volunteers to take the test will regularly record how they feel after vaccination in the electronic diaries. The vaccine will be improved according to the symptoms that arise
